Discounted Cash Flow (DCF) Analysis Levered
Cosmos Health Inc. (COSM)
$6.54
-0.28 (-4.11%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 30.01 | 37.08 | 39.68 | 55.41 | 56.24 | 66.32 | 78.21 | 92.23 | 108.76 | 128.25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -8.76 | -1.56 | -4.79 | -11.50 | -7.10 | -10.46 | -12.33 | -14.54 | -17.15 | -20.22 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.06 | -0.50 | -0.67 | -0.12 | -0.58 | -0.59 | -0.70 | -0.83 | -0.98 | -1.15 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -8.82 | -2.06 | -5.46 | -11.62 | -7.68 | -11.05 | -13.03 | -15.37 | -18.12 | -21.37 |
Weighted Average Cost Of Capital
| Share price | $ 6.54 |
|---|---|
| Beta | 3.076 |
| Diluted Shares Outstanding | 0.53 |
| Cost of Debt | |
| Tax Rate | -98.72 |
| After-tax Cost of Debt | 11.37% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 18.035 |
| Total Debt | 24.83 |
| Total Equity | 3.48 |
| Total Capital | 28.31 |
| Debt Weighting | 87.70 |
| Equity Weighting | 12.30 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 30.01 | 37.08 | 39.68 | 55.41 | 56.24 | 66.32 | 78.21 | 92.23 | 108.76 | 128.25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.76 | -1.56 | -4.79 | -11.50 | -7.10 | -10.46 | -12.33 | -14.54 | -17.15 | -20.22 |
| Capital Expenditure | -0.06 | -0.50 | -0.67 | -0.12 | -0.58 | -0.59 | -0.70 | -0.83 | -0.98 | -1.15 |
| Free Cash Flow | -8.82 | -2.06 | -5.46 | -11.62 | -7.68 | -11.05 | -13.03 | -15.37 | -18.12 | -21.37 |
| WACC | ||||||||||
| PV LFCF | -9.85 | -10.35 | -10.88 | -11.44 | -12.02 | |||||
| SUM PV LFCF | -54.55 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 12.19 |
| Free cash flow (t + 1) | -21.80 |
| Terminal Value | -213.91 |
| Present Value of Terminal Value | -120.36 |
Intrinsic Value
| Enterprise Value | -174.90 |
|---|---|
| Net Debt | 24.54 |
| Equity Value | -199.45 |
| Shares Outstanding | 0.53 |
| Equity Value Per Share | -374.68 |